S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
ASX:MPH

Mediland Pharm Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume4,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Mediland Pharm Limited engages in the retail sale of health, beauty, and wellness products in Australia and New Zealand. The company's stores also offers luxury products, such as opal and pink diamond jewelry pieces, souvenirs and gifts, luxurious bedding and rugs. It operates through three retail stores in Sydney, Melbourne, and the Gold Coast, Australia; and one store in Auckland, New Zealand. The company was founded in 2002 and is headquartered in Sydney, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.56 out of 5 stars

Industry, Sector and Symbol

Stock Exchange ASX
Industry Household & Personal Products
Sub-IndustryN/A
SectorConsumer Defensive
Current SymbolASX:MPH
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.medilandpharm.com.au
Phone61 2 9261 1594
EmployeesN/A

Debt

Debt-to-Equity Ratio50.25
Current Ratio2.01
Quick Ratio1.73

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$23.30 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.03 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MPH News and Ratings via Email

Sign-up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mediland Pharm (ASX:MPH) Frequently Asked Questions

Who are some of Mediland Pharm's key competitors?

Some companies that are related to Mediland Pharm include Asaleo Care (AHY), Beiersdorf Aktiengesellschaft (BDRFY), Beiersdorf Aktiengesellschaft (BDRFF), Biologix Hair (BLGX), BOD Australia (BDA), BWX (BWX), Dogness International (DOGZ), ESSITY AKTIEBOL/S (ESSYY), Henkel AG & Co KGaA (HEN3), HENKEL AG & CO/S (HENOY), Human Pheromone Sciences (EROX), Joey New York (JOEY), KAO (KAOOY), KAO (KSRYY) and Kimberly Parry Organics (KPOC).
View all competitors.

Who are Mediland Pharm's key executives?

Mediland Pharm's management team includes the following people:
  • Mr. Yeshween Mudaliar, MD & Director
  • Ms. Jessie Tao, CFO & Director
  • Mr. Jhon Shen, Exec. Director
  • Ms. Indira Naidu, Company Sec.

What is Mediland Pharm's stock symbol?

Mediland Pharm trades on the ASX under the ticker symbol "MPH."

How big of a company is Mediland Pharm?

Mediland Pharm has a market capitalization of $0.00 and generates $23.30 million in revenue each year.

What is Mediland Pharm's official website?

The official website for Mediland Pharm is www.medilandpharm.com.au.

How can I contact Mediland Pharm?

The company can be reached via phone at 61 2 9261 1594.

This page was last updated on 10/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.